| [1] | WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018 |
| [2] | Li KeZhi, Wei JiaKang, Han ZhiWei, Chou WenXia, Chen XinXin, Huang Shan, He JianBo, Wu GuoBin, Chen Chuang. Changes in intestinal flora in patients with primary liver cancer after transcatheter arterial chemoembolization[J]. Journal of Clinical Hepatology, 2020, 36(5): 1043-1049. doi: 10.3969/j.issn.1001-5256.2020.05.019 |
| [3] | Ma MingYuan, Lin GangYi, Cai ZongYang, Luo HeSan, Wu ShengXi. Efficacy and safety of microsphere transarterid chemoembolization combined with radiotherapy versus microsphere transarterial chemoembolization alone in treatment of patients with unresectable liver cancer[J]. Journal of Clinical Hepatology, 2019, 35(11): 2489-2494. doi: 10.3969/j.issn.1001-5256.2019.11.020 |
| [4] | Sun Yu, Zhang HongHai, Sheng ShouPeng, Li Cong, Yuan ChunWang, Cui ShiChang, Hu CaiXia, Liu BoJun, Li XingMing, Zhang YongHong, Zheng JiaSheng. Clinical effect of transcatheter arterial chemoembolization combined with radiofrequency ablation in treatment of Barcelona Clinical Liver Cancer stage B primary liver cancer and influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2019, 35(4): 818-824. doi: 10.3969/j.issn.1001-5256.2019.04.022 |
| [5] | Yin WeiLi, Lian Jia, Xiao ShiXiang, Xiang HuiLing, Liu Ying, Qian BaoXin, Wang Tao, Li Ying, Jin YuXia, Han Tao. Clinical effect of drug-eluting beads and conventional transcatheter arterial chemoembolization in treatment of unresectable liver cancer: A meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1270-1275. doi: 10.3969/j.issn.1001-5256.2019.06.018 |
| [6] | Wang Hui, Pan YuGuo, Xia JinTang, Zhou MiMi, Cai Chun. Clinical effect of transcatheter arterial chemoembolization in treatment of primary liver cancer: application and research advances[J]. Journal of Clinical Hepatology, 2018, 34(2): 414-418. doi: 10.3969/j.issn.1001-5256.2018.02.044 |
| [7] | Wang ChunMei, Ceng JianTing, Luo XianZhang, Liu Ya. Clinical effect of S-1 in treatment of circulating tumor cell-positive patients after radical surgery for primary hepatic carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(3): 513-516. doi: 10.3969/j.issn.1001-5256.2018.03.012 |
| [8] | Wu Jian, Yin Fang, Luo GuanHong, Zheng YangYang, Li Hong, Zhu ShaoHua, Zhang Jing, Zhou XinMin. Clinical effect and safety of transarterial chemoembolization combined with apatinib in treatment of advanced primary liver cancer[J]. Journal of Clinical Hepatology, 2018, 34(4): 775-778. doi: 10.3969/j.issn.1001-5256.2018.04.016 |
| [9] | Li Hao, Duan XuHua, Han XinWei, Ren JianZhuang, Li FengYao, Kuang DongLin, Li FangZheng. Clinical effect of transarterial chemoembolization combined with radiofrequency ablation in treatment of rabbit VX2 liver tumors[J]. Journal of Clinical Hepatology, 2018, 34(4): 779-783. doi: 10.3969/j.issn.1001-5256.2018.04.017 |
| [10] | Wang QiaoYu, Pan Jie, Zhou YuanMin. Clinical effect of transarterial chemoembolization combined with endovascular implantation of iodine-125 seeds in treatment of primary liver cancer complicated by portal vein tumor thrombus[J]. Journal of Clinical Hepatology, 2018, 34(1): 137-141. doi: 10.3969/j.issn.1001-5256.2018.01.028 |
| [11] | An DongJun, An Lin, Zhang Cheng, Zhao WeiAn, Han Li. Efficacy of laparoscopic microwave ablation in treatment of malignant liver tumors[J]. Journal of Clinical Hepatology, 2017, 33(11): 2158-2161. doi: 10.3969/j.issn.1001-5256.2017.11.021 |
| [12] | Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014 |
| [13] | Yu Tong, Zhai XiaoFeng, Liu Qun, Meng YongBin, Lu JianYing, Chen Zhe. Clinical effect and safety of hepatic arterial infusion of cinobufotalin injection combined with lipiodol chemoembolization in treatment of Barcelona Clinic Liver Cancer stage C primary liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(2): 281-285. doi: 10.3969/j.issn.1001-5256.2017.02.015 |
| [14] | Zhao GuangSheng, Ren ZhiZhong, Liu Ying, Zhou Jun, Zhang YueWei, Zhang Ming. Effect of live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules in treatment of adverse events and complications after transcatheter arterial chemoembolization[J]. Journal of Clinical Hepatology, 2016, 32(1): 88-91. doi: 10.3969/j.issn.1001-5256.2016.01.015 |
| [15] | Wang Xin, Zhang Hui, He XiaoJun, Li XinHui, Liu Yang, Zhang HongYi. Clinical effect of precise sequential interventional therapy in patients with unresectable hepatic metastasis after surgery for colorectal cancer[J]. Journal of Clinical Hepatology, 2016, 32(3): 518-521. doi: 10.3969/j.issn.1001-5256.2016.03.025 |
| [16] | Wang BaoXin, Zhang Rui, Hu XinHua, Qi XiuHeng, Xiao FangFang, Xing HongJian, Zou QingHua, Guo Qian, Wu ZhenMing. Efficacy of raltitrexed combined with transcatheter arterial chemoembolization in treatment of advanced colorectal cancer with liver metastasis[J]. Journal of Clinical Hepatology, 2016, 32(4): 742-745. doi: 10.3969/j.issn.1001-5256.2016.04.028 |
| [17] | Sun Wei, Ding XiaoYan, Chen JingLong. Clinical effect and safety of percutaneous radiofrequency ablation following transcatheter arterial chemoembolization in treatment of primary liver cancer in high-risk locations[J]. Journal of Clinical Hepatology, 2016, 32(12): 2337-2341. doi: 10.3969/j.issn.1001-5256.2016.12.021 |
| [18] | Yang ShengHua, Zhang ChengHua, Du LingHong. Relationship between ways of nutritional support and immune function in patients with malignant obstructive jaundice after PTCD[J]. Journal of Clinical Hepatology, 2014, 30(11): 1148-1152. doi: 10.3969/j.issn.1001-5256.2014.11.014 |
| [19] | Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001 |
| [20] | Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365. |
DownLoad: